Literature DB >> 23392390

Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery.

Lise Christensen1, Vibeke Breiting, Thomas Bjarnsholt, Steffen Eickhardt, Estrid Høgdall, Martin Janssen, Norbert Pallua, Sebastian A J Zaat.   

Abstract

BACKGROUND: The etiology of long-lasting adverse reactions to gel fillers used in cosmetic surgery is not known. Bacterial infection and immunological reaction to the product have been suggested.
METHODS: We performed a case-control study, with 77 biopsies and 30 cytology specimens originating from 59 patients with adverse reactions to polyacrylamide gel, and 54 biopsies and 2 cytology specimens from 28 control subjects with no adverse reactions. Samples from 5 patients and 4 controls could not be investigated for presence of bacteria owing to limited material. Samples from the remaining 54 patients and 24 controls were systematically examined for the presence of bacteria by culture, 16S rRNA gene sequencing, Gram stain, and fluorescence in situ hybridization.
RESULTS: Bacteria, mostly normal skin bacteria such as Staphylococcus epidermidis and Propionibacterium acnes, were identified in bacteriologically investigated samples from 53 of 54 patients (98%), and in none of the 24 controls (0%). The bacteria were lying in small clusters, which in symptomatic lesions were detected up to 5 years postinjection.
CONCLUSIONS: Commensal bacteria of low virulence are capable of producing long-term infection in the presence of polyacrylamide filler in cosmetic surgery, possibly due to a biofilm mode of growth. Adequate skin preparation and use of sterile technique in these procedures are mandatory, but antibiotic prophylaxis prior to injection of nondegradable gels like polyacrylamide should be explored as well.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392390     DOI: 10.1093/cid/cit067

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Immediate nor Delayed Type Hypersensitivity Plays a Role in Late Inflammatory Reactions After Hyaluronic Acid Filler Injections.

Authors:  Tom Decates; Jonathan Kadouch; Peter Velthuis; Thomas Rustemeyer
Journal:  Clin Cosmet Investig Dermatol       Date:  2021-05-31

Review 2.  Emerging permanent filler technologies: focus on Aquamid.

Authors:  Paul S Yamauchi
Journal:  Clin Cosmet Investig Dermatol       Date:  2014-10-10

Review 3.  Managing Complications of Fillers: Rare and Not-So-Rare.

Authors:  Eckart Haneke
Journal:  J Cutan Aesthet Surg       Date:  2015 Oct-Dec

Review 4.  Nonvascular Complications of Injectable Fillers-Prevention and Management.

Authors:  Kuldeep Singh; Shahin Nooreyezdan
Journal:  Indian J Plast Surg       Date:  2020-12-24

Review 5.  The Aetiopathogenesis of Late Inflammatory Reactions (LIRs) After Soft Tissue Filler Use: A Systematic Review of the Literature.

Authors:  Y Bachour; J A Kadouch; F B Niessen
Journal:  Aesthetic Plast Surg       Date:  2021-04-28       Impact factor: 2.326

6.  Drug Delivery from Hyaluronic Acid-BDDE Injectable Hydrogels for Antibacterial and Anti-Inflammatory Applications.

Authors:  Jon Andrade Del Olmo; Leyre Pérez-Álvarez; Virginia Sáez Martínez; Sandra Benito Cid; Raúl Pérez González; José Luis Vilas-Vilela; José María Alonso
Journal:  Gels       Date:  2022-04-06

Review 7.  Sub-Optimal Treatment of Bacterial Biofilms.

Authors:  Tianyan Song; Marylise Duperthuy; Sun Nyunt Wai
Journal:  Antibiotics (Basel)       Date:  2016-06-22

8.  Novel Forehead Augmentation Strategy: Forehead Depression Categorization and Calcium-Hydroxyapatite Filler Delivery after Tumescent Injection.

Authors:  Jongseo Kim
Journal:  Plast Reconstr Surg Glob Open       Date:  2018-09-06

9.  Bactericidal Property of Oregano Oil Against Multidrug-Resistant Clinical Isolates.

Authors:  Min Lu; Tianhong Dai; Clinton K Murray; Mei X Wu
Journal:  Front Microbiol       Date:  2018-10-05       Impact factor: 5.640

Review 10.  [What's new in clinical dermatology?].

Authors:  M Janier
Journal:  Ann Dermatol Venereol       Date:  2013-11       Impact factor: 0.777

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.